New shot aims to shield patients with rare immune disorders from serious infections
Disease control
Ongoing
This study tests a medicine called Newnorm, given as a shot under the skin, in 50 people aged 2 to 75 with primary immunodeficiency diseases (weak immune systems). The goal is to see if it can prevent serious bacterial infections and keep antibody levels stable. Participants rece…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated May 11, 2026 20:41 UTC